Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SeroVital effects on T3 levels
NCT02987868Completed
- Sponsor
- Pennington Biomedical Research Center
- Start
- Oct 2011
- Primary completion
- Dec 2011
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Pennington Biomedical Research Center. Primary endpoint: Percent Change of Triiodthyronine Over Baseline. Started Oct 2011; status: completed.
Beyond the preview
Go deeper on NCT02987868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02987868.